Article
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
Proceedings of the National Academy of Sciences of the United States of America - 15 Dec 1991
Richman D, Shih C K, Lowy I, Rose J, Prodanovich P, Goff S, Griffin J
Abstract excerpt
We have recently described a nonnucleoside compound that specifically inhibits the reverse transcriptase of human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS. This compound, nevirapine (BI-RG-587), interacts with highly conserved tyrosine residues at positions 181 and 188 in the reverse transcriptase to inhibit the recombinant enzyme and virus replication in cell culture with 50% inhibitory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
